October 7, 2023
CD19-directed CAR T-cell therapy Breyanzi has been approved by the European Commission (EC) based on significant results from a lymphoma Phase III trial. The European Commission […]
October 4, 2023
What is CAR T cell therapy? CAR T cell therapy is a type of immunotherapy that uses genetically engineered T cells to target and kill cancer […]
